Fundraising FoxThuja Capital
Venture capitalUtrecht · Seed–Series B · 7 people tracked
Also known as Thuja
Find your way into Thuja Capital
Sign up to see every warm intro you have to Thuja Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Thuja Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Thuja Capital invests in early-stage biotechnology and medical device companies. The firm focuses on healthcare and life science innovations.
Team · 7 people
from public directories
Founder mafia
2 people who came through Thuja Capital went on to found or lead other companies.
What they invest in
from 9 of 16 portfolio companiesBiotech ×8Healthtech ×7Medical Devices ×6Deep Tech ×3AgTech ×1Digital Health ×1FoodTech ×1Hardware ×1
HQs:Netherlands×5Germany×1Ireland×1United States×1
Investments · 16 tracked
founders shown can be your intro pathBy year:2025 · 12023 · 12020 · 12013 · 14 dated
Artica Therapeutics develops orally bioavailable small molecule inhibitors that use covalent chemistry to achieve antibody-like efficacy, positioned as an "antibody-in-a-pill" approach.
BiotechDeep TechHealthtech
Tjeerd Barf(Co-founder & CEO)inArwin Ridder(Co-founder & COO)inAd IJzerman(Co-founder & SAB Chair)inJason(Chief Scientific Officer)in
Co-investorsBioGeneration VenturesSeroba Life SciencesBGV
ATRO Medical is a Dutch clinical-stage orthopedic company developing the Artimis artificial meniscus implant (prosthesis) for patients with chronic knee pain after meniscectomy.
BiotechHealthtechMedical DevicesNijmegen, NL
Tony van Tienen(Founder)in
Co-investorsBOM
Cristal Therapeutics develops therapeutics in the life sciences sector.
BiotechDeep TechDigital HealthMedical DevicesUtrecht, NL
Dr. Cristianne Rijcken(Chief Scientific Officer and Founder)Dr. Joost Holthuis(Co-founder and former CEO)
Co-investorsBioGeneration VenturesChemelot VenturesBOMDroia VenturesBrightlands Venture Partners
Tacalyx develops novel anticancer therapeutics that target Tumor-Associated Carbohydrate Antigens (TACAs), including antibody-drug conjugate programs.
BiotechDeep TechMedical DevicesBerlin, DE
Peter Seeberger(Co-founder (Prof. Dr.))Oren Moscovitz(CSO & Co-founder)
Co-investorscoparionCreathor VenturesKurma PartnersBoehringer Ingelheim Venture FundApollo Health Ventures
Alesta Therapeutics develops therapies for rare diseases, with research focused on genetic diseases and oncology.
BiotechHealthtech
Ilan Ganot(CEO)inBenit Maru(CMO)Matthias Van Woensel(CSO)in
Co-investorsDroia VenturesFrazier Life SciencesNovartis Venture FundRV Invest GmbHFrazier Healthcare PartnersMPM BioImpact+1 more
The company develops therapies for people with severe autoimmune diseases.
BiotechHealthtechMedical Devices
Co-investorsAvoro Capital AdvisorsBioGeneration VenturesHBM Healthcare InvestmentsMPM BioImpactPMVSeventure Partners+2 more
Cardiac Booster develops cardiac support technology for use in treating heart conditions.
BiotechHardwareHealthtechMedical DevicesGalway, IE
Florian Ludwig(CEO)inGerard Kilcommins(COO)Greg Mann(CFO)Patrick Griffin(VP Technology Development)inJeff Grainger(VP of Legal Affairs)Daragh Moloney(HR Director)in
Co-investorsAscension VenturesLightstone Ventures
Rahul Bhatia(Founder)Rakesh Gangwal(Founder)
Co-investorsEra VenturesOak HC/FTQbic Fund
Mellon Medical manufactures a surgical instrument for abdominal wall closure featuring a double-pointed needle, ergonomic jaws, and atraumatic needle-suture combination.
HealthtechMedical DevicesRotterdam, NL
Co-investorsBioGeneration VenturesBOM
NutriLeads employs in-house experts with backgrounds in food technology, microbiology, nutrition, and health across academic and industry sectors.
AgTechBiotechFoodTechHealthtechWellness & FitnessWageningen, NL
Co-investorsSHIFT Investdsm-firmenich VenturingIcos CapitalOost NL
Neuromodulation therapy for migraine relief.
Eindhoven, NL
Hubert Martens(Co-founder; Chief Executive Officer)Daniel Schobben(Co-founder; Chief Innovation Officer)Dr. Wim Pollet(Co-founder; Chief Medical Officer)
Co-investorsDolby Family VenturesInkefInnovation IndustriesLevensohn Venture PartnersPanakes PartnersSHS Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
BioCerosEsoBiotecFundaMental PharmaGradient Denervation TechnologiesSmall Molecules
Frequently asked questions
- How many investments has Thuja Capital made?
- Thuja Capital has 16 tracked investments, including 1 dated in the last 24 months.
- What stage does Thuja Capital invest at?
- Thuja Capital invests at the Seed, Series A, Series B stages.
- What sectors does Thuja Capital focus on?
- Thuja Capital focuses on Biotech, Medical Devices.
- Where is Thuja Capital located?
- Thuja Capital is headquartered in Utrecht, NL.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Blackbird is a venture capital firm that backs founders from the earliest stages, with a focus on ambitious technology startups across Australia and New Zealand.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.